Screener
BioLife Solutions BLFS Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | 1.6%— | -16.6%— | -18.1%— | —— | —— | |
| Returns | ||||||
| Return on invested capital | 0.4%+5.5pp | -4.8%-4.1pp | -5.2%-3.6pp | -4.9%— | -5.1%— | |
| Efficiency | ||||||
| Asset turnover | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×— | 0.2×— | |
| Liquidity | ||||||
| Current ratio | 9.7×+5.3× | 7.3×+2.6× | 5.9×+1.4× | 4.7×+1.9× | 4.4×+1.6× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0.1×-0.1× | 0.1×0.0× | |
| Net debt / EBITDA | -2.5×— | —— | —— | —— | —— | |
| Per Share | ||||||
| Book value per share | $8.52+17.3% | $7.56+3.7% | $7.64+0.9% | $7.26+3.0% | $7.26+3.9% | |
| Valuation | ||||||
| Market capitalization | $1.66B+64.3% | $921.56M-14.0% | $1.16B-3.3% | $1.22B+5.8% | $1.04B+5.0% | |
| Price / sales | 16.1×+3.8× | 9.4×-4.3× | 12.6×-3.5× | 13.8×— | 12.6×— | |
| Price / book | 3.9×+1.0× | 2.5×-0.6× | 3.1×-0.3× | 3.5×-0.1× | 3×-0.1× | |
| EV / EBITDA | 497.4×— | —— | —— | —— | —— |
FAQ
- What are BioLife Solutions's profit margins?
- BioLife Solutions (BLFS) runs a 67.2% gross margin and a 1.6% operating margin, with a -68.7% net margin.
- Where do BioLife Solutions's ratios come from?
- Every ratio is computed from BioLife Solutions's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
